Low level quantitation of Fluticasone and Salmeterol from plasma using LC/MS/MS

The combination drug of fluticasone/ salmeterol contains fluticasone propionate and salmeterol.
Fluticasone, a corticosteroid, is the anti-inflammatory component of the combination, while salmeterol treats constriction of the airways. Together, they relieve the symptoms of coughing, wheezing and shortness of breath related to asthma and Chronic Obstructive Pulmonary Disorder (COPD). LC/MS/MS has been increasingly employed in pharmacokinetic studies due to its specificity and sensitivity. This also allows the development of assays with minimal sample preparation.

Content Type:
Paper
Document Number:
PO-CON1547E
Product Type:
Mass Spectrometry, Liquid Chromatograph-Mass Spectrometry
Keywords:
salmeterol, fluticasone, plasma, corticosteroid, Chronic Obstructive Pulmonary Disorder (COPD), Pharmaceutical, Life Science, Healthcare, Development (Formulation, Scale-up, Method development), Drug synthesis and purification, LCMS-8050
Language:
English
File Name:
ipo115065.pdf
File Size:
1,331kb

View Article

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.

Top of This Page

Please select your country or region.

Transferring to the local website of your country or region.

Transfer to
https://www.ssi.shimadzu.com/